Sharekhan

Entero Healthcare Solutions Ltd

Wed 21/05/2025,15:42:15 | NSE : ENTERO

₹ 1404.60-39.00 (-2.70%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1449.00

Previous Close

₹ 1443.60

Volume

33020

Mkt Cap ( Rs. Cr)

₹6111.09

High

₹ 1457.90

Low

₹ 1397.00

52 Week High

₹ 1584.25

52 Week Low

₹ 991.10

Book Value Per Share

₹ 386.79

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Entero Healthcare Solutions Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1404.60

75

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

75

Option Chain

Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Entero Healthcare So - Disclosure under SEBI Takeover Regulations

    15 May 2025, 5:23PM OrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of I
  • Entero Healthcare So - Submission Of Monitoring Agency Report For The Quarter Ended March 31, 2025

    9 May 2025, 12:26PM Submission of Monitoring Agency Report for the quarter ended March 31, 2025.
  • Entero Healthcare So - Monitoring Agency Report

    9 May 2025, 12:25PM Monitoring Agency Report issued by the ICRA Limited for the quarter ended March 31, 2025
  • Entero Healthcare So - Disclosure under SEBI Takeover Regulations

    8 May 2025, 4:50PM Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial A
  • Entero Healthcare So - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    28 Apr 2025, 7:12PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    22 Apr 2025, 9:28PM Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Entero Healthcare So has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    15 Apr 2025, 7:00AM As of March 2025, 52.42% is owned by Promoters and 47.58% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 14.41% and Fore
  • Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 12:27PM Certificate under Regulation 74(5) of Securities and Exchange Board of India(Depositories and Participants) Regulations, 2018 for the Quarter ended Ma
  • Entero Healthcare So - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 12:28PM Certificate under Regulation 74(5) of SEBI (Depositories and Participant) Regulation, 2018 for the quarter ended March 31, 2025.
  • Entero Healthcare So - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    1 Apr 2025, 3:12PM Entero Healthcare Solutions Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    28 Mar 2025, 8:27PM Update on intimation on acquisition of balance equity shares in Getwell Medicare Solution Private Limited to make it wholly owned subsidiary Company.
  • Entero Healthcare So - Acquisition

    28 Mar 2025, 8:27PM Entero Healthcare Solutions Limited has informed the Exchange about Updating on acquisition of balance equity shares in Getwell Medicare Solution Priv
  • Entero Healthcare So - Trading Window

    24 Mar 2025, 8:11PM Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R
  • Entero Healthcare So - Trading Window-XBRL

    24 Mar 2025, 8:07PM Entero Healthcare Solutions Limited has informed the Exchange about Closure of Trading Window
  • Entero Healthcare So - Sale or disposal-XBRL

    24 Mar 2025, 10:24AM Entero Healthcare Solutions Limited has informed the Exchange regarding Sale or disposal of unit(s)/division(s)/subsidiary
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Change in Management

    21 Mar 2025, 2:49PM Resignation and appointment of Chief Financial Officer
  • Entero Healthcare So - Change in Management

    21 Mar 2025, 2:48PM Entero Healthcare Solutions Limited has informed the Exchange about change in Management
  • Entero Healthcare So - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    21 Mar 2025, 2:37PM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting Held On March 21, 2025

    21 Mar 2025, 2:27PM Outcome of Board Meeting held on March 21, 2025
  • Entero Healthcare So - Outcome of Board Meeting

    21 Mar 2025, 2:25PM Entero Healthcare Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on March 21, 2025.
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Mar 2025, 9:12PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of Investor meet to be held on March 26, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Mar 2025, 9:07PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on March 26, 2025 at 12:00 Noon (IST)
  • Entero Healthcare So - Press Release

    19 Mar 2025, 11:17AM Entero Healthcare Solutions Limited has informed the Exchange regarding a press release dated March 19, 2025, titled ""Entero launches HealthEdge pr
  • Entero Healthcare So - Press Release

    19 Mar 2025, 10:37AM Entero Healthcare Solutions Limited has informed the Exchange regarding a press release dated March 19, 2025, titled ""Entero launches HealthEdge pr
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 Mar 2025, 10:37AM Submission of information pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015- Media Release/Press Rel
  • Entero Healthcare So - General Updates

    6 Mar 2025, 5:39PM Entero Healthcare Solutions Limited has informed the Exchange about General Updates on investment in the equity shares of Getwell Medicare Solutions P
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    6 Mar 2025, 5:49PM Update on investment in equity shares of Getwell Medicare Solution Private Limited (\Subsidiary\) issued on Rights Basis.
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Mar 2025, 5:33PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of Investor meet to be held on March 11, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    5 Mar 2025, 5:29PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on March 11, 2025 at 05:00 PM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Feb 2025, 6:54PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of Investor meet to be held on March 05, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Feb 2025, 6:50PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on March 05, 2025 at 08:00 AM (IST)
  • Entero Healthcare So - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    21 Feb 2025, 9:45PM Entero Healthcare Solutions Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Key fundamentals

Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock 

Name March-24 March-23 March-22 March-21
Assets 1626.414 675.232 581.205 486.4381
Liabilities 1626.414 675.232 581.205 486.4381
Equity 43.494 4.112 3.85 0.1002
Gross Profit -34.494 -43.916 -53.716 -36.9478
Net Profit 38.44 -12.455 -40.847 -18.1512
Cash From Operating Activities -75.65 -56.909 -44.698 -68.1958
NPM(%) 12.08 -7 -29.75 -18.17
Revenue 318.161 177.69 137.286 99.8955
Expenses 352.655 221.606 191.002 136.8433
ROE(%) 2.28 -0.74 -2.42 -1.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.15 -0.84 26.88 824.01 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.06 0.78 308.58 3002.57 14.01 0.68
Vaishali Pharma Ltd 12.85 -1.15 428.33 1547.64 2.76 0.00
Astec Lifesciences Ltd 701.25 -1.59 0.00 2831.16 -687.11 0.00

Company Info

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Read More

Parent Organisation

Entero Healthcare Solutions Ltd.

Founded

10/01/2018

Managing Director

Mr.Prabhat Agrawal

NSE Symbol

ENTEROEQ

FAQ

The current price of Entero Healthcare Solutions Ltd is ₹ 1404.60.

The 52-week high for Entero Healthcare Solutions Ltd is ₹ 1457.90 and the 52-week low is ₹ 1397.00.

The market capitalization of Entero Healthcare Solutions Ltd is currently ₹ 6111.09. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Entero Healthcare Solutions Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Entero Healthcare Solutions Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Entero Healthcare Solutions Ltd shares.

The CEO of Entero Healthcare Solutions Ltd is Mr.Prabhat Agrawal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT